Profile data is unavailable for this security.
About the company
ECO Animal Health Group plc is a United Kingdom-based global animal health company. The Company is focused on improving the health and welfare of pigs and poultry. It is engaged in developing and marketing branded veterinary pharmaceuticals globally, in antibiotics and vaccines for pigs and poultry. The Company is focused on providing solutions to respiratory and enteric diseases in pigs and poultry. Its segment includes the United Kingdom, China and Japan, North America, South and Southeast Asia, Latin America, Europe, and the Rest of the World. It provides products for swine and poultry to treat illness, improving health and performance. The Company’s lead product, Aivlosin, is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry. It also offers a range of products to treat parasites in cattle, sheep and pigs under the brand name Ecomectin.
- Revenue in GBP (TTM)85.81m
- Net income in GBP3.02m
- Incorporated1984
- Employees219.00
- LocationECO Animal Health Group PLCThe Grange100 The High Street, SouthgateLONDON N14 6BNUnited KingdomGBR
- Phone+44 20 8447 8899Fax+44 20 8447 9292
- Websitehttps://www.ecoanimalhealthgroupplc.com/
Peer analysis
| Company | Revenue (TTM) | Net income (TTM) |
|---|---|---|
| Sigachi Industries Ltd | 41.06m | -4.46m |
| Fortress Biotech Inc | 45.77m | -3.92m |
| Lincoln Pharmaceuticals Ltd | 51.26m | 6.49m |
| Eco Animal Health Group Plc | 85.81m | 3.02m |
| Vita Life Sciences Ltd | 44.12m | 4.80m |
| Biostem Technologies Inc | 172.75m | 14.84m |
Institutional shareholders
| Holder | Shares | % Held |
|---|---|---|
| Schroder Investment Management Ltd.as of 08 Dec 2025 | 12.84m | 18.95% |
| SFM UK Management LLPas of 05 Aug 2025 | 7.26m | 10.71% |
| FIL Investment Advisors (UK) Ltd.as of 30 Jun 2025 | 5.94m | 8.77% |
| Lombard Odier Asset Management (Europe) Ltd.as of 30 Jun 2025 | 4.55m | 6.71% |
| Canaccord Genuity Wealth Ltd.as of 24 Aug 2022 | 3.38m | 5.00% |
| AXA Investment Managers UK Ltd.as of 21 Mar 2025 | 3.35m | 4.95% |
| Chelverton Asset Management Ltd.as of 30 Jun 2025 | 3.13m | 4.61% |
| Killik & Co. LLPas of 16 Jan 2026 | 2.00m | 2.96% |
| Danske Bank A/S (Investment Management)as of 07 Feb 2023 | 1.85m | 2.74% |
| Artemis Investment Management LLPas of 30 Jun 2025 | 1.69m | 2.49% |
